Papers - YAMAMOTO Kenta
-
Immune-related liver injury is a poor prognostic factor in patients with non-small cell lung cancer treated with immune checkpoint inhibitors Reviewed
Takafumi Yamamoto, Takanori Ito, Tetsunari Hase, Masatoshi Ishigami, Kazuyuki Mizuno, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Hirofumi Shibata, Takahiro Hatta, Naoyuki Yogo, Satoshi Yasuda, Hidenori Toyoda, Takashi Abe, Hiroki Kawashima, Naozumi Hashimoto, Mitsuhiro Fujishiro
Cancer investigation 2021.10
-
The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia: HCC after HCV eradication in hemophilia. Reviewed
Inukai Y, Imai N, Yamamoto K, Ito T, Ishizu Y, Honda T, Okamoto S, Kanematsu T, Suzuki N, Matsushita T, Ishigami M, Fujishiro M
Annals of hepatology 2021.9
-
Revisiting Prognosis After Liver Transplant in Patients Positive for Hepatitis C Virus: Focus on Hepatitis C Recurrence-Unrelated Complications. Reviewed
Ishigami M, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Kamei H, Ogura Y, Fujishiro M
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation Vol. 19 ( 9 ) page： 935 - 942 2021.9
-
Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies Reviewed
Ito T, Ishigami M, Yamamoto T, Mizuno K, Yamamoto K, Imai N, Ishizu Y, Honda T, Kawashima H, Yasuda S, Toyoda H, Yokota K, Hase T, Nishio N, Maeda O, Kato M, Hashimoto N, Hibi H, Kodera Y, Sone M, Ando Y, Akiyama M, Shimoyama Y, Fujishiro M
Hepatology international Vol. 15 ( 5 ) page： 1278 - 1287 2021.8
-
Quality of Life in patients with nonalcoholic fatty liver disease: Structure and related factors focusing on illness uncertainty. Reviewed
Naoki Ozawa Kazuki Sato Ayumi Sugimura Shigeyoshi Maki Taku Tanaka Kenta Yamamoto Takanori Ito Yoji Ishizu Teiji Kuzuya Takashi Honda Masatoshi Ishigami Mitsuhiro Fujishiro Tetsuya Ishikawa Shoko Ando
Japan journal of nursing science 2021.3
-
Progression After Molecular Targeted Agents: Hepatic Arterial Changes and Transarterial Chemoembolization in Hepatocellular Carcinoma Reviewed
NORITAKA MATSUDA, NORIHIRO IMAI, TEIJI KUZUYA, KENTA YAMAMOTO, TAKANORI ITO, YOJI ISHIZU, TAKASHI HONDA, MASATOSHI ISHIGAMI and MITSUHIRO FUJISHIRO
In vivo. Vol. 35 ( 2 ) page： 1185 - 1189 2021.3
-
Impact of visceral fat accumulation on the prognosis of patients with cirrhosis Reviewed
Yoji Ishizu Masatoshi Ishigami Takashi Honda Norihiro Imai Takanori Ito Kenta Yamamoto Mitsuhiro Fujishiro
Clinical Nutrition ESPEN 2021.1
-
Safety and efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma patients with haemophilia Reviewed
Takafumi Yamamoto Norihiro Imai Kenta Yamamoto Takanori Ito Yoji Ishizu Takashi Honda Shuichi Okamoto Takeshi Kanematsu Nobuaki Suzuki Tadashi Matsushita Masatoshi Ishigami Mitsuhiro Fujishiro
Haemophilia Vol. 27 ( 1 ) page： 100 - 107 2021.1
-
Tolerability of Molecular-targeted Agents for Hepatocellular Carcinoma Treatment in Haemophiliacs Reviewed
Yamamoto T, Imai N, Yamamoto K, Ito T, Ishizu Y, Honda T, Okamoto S, Kanematsu T, Suzuki N, Matsushita T, Ishigami M, Fujishiro M.
Anticancer research Vol. 40 ( 5 ) page： 2569 - 2573 2021
-
The albumin-bilirubin score as a predictor of outcomes in Japanese patients with PBC: an analysis using time-dependent ROC Reviewed
Ito T, Ishigami M, Morooka H, Yamamoto K, Imai N, Ishizu Y, Honda T,Nishimura D, Tada T, Yasuda S, Toyoda H, Kumada T, Fujishiro
Scientific reports. Vol. 10 ( 1 ) page： 17812 2020.10
-
Antifibrotic Effects of 1,25(OH)2D3 on Nonalcoholic Steatohepatitis in Female Mice.
Ma, Lingyun, Masatoshi Ishigami, Takashi Honda, Shinya Yokoyama, Kenta Yamamoto, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Yoshiki Hirooka, and Hidemi Goto.
Digestive Diseases and Sciences Vol. 64 ( 9 ) page： 2581–90 2019
-
この症例に学ぶ 体外式腹部超音波検査にて描出しえた早期胃癌の一例 Invited Reviewed
山本 健太, 熊田 卓, 久永 康宏, 金森 明, 多田 俊史, 北畠 秀介, 曽根 康博
日本消化器がん検診学会雑誌 Vol. 52 ( 3 ) page： 387-392 2014.5
-
術中色素動注法が切除範囲決定に有用であった小腸angioectasiaの1例(原著論文/症例報告) Reviewed
山本 健太, 熊田 卓, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 金森 明, 多田 俊史, 北畠 秀介, 曽根 康博
日本消化器病学会雑誌 Vol. 111 ( 4 ) page： 773-778 2014.4
-
肝細胞癌と鑑別が困難であったreactive lymphoid hyperplasiaの1例 Reviewed
山本 健太, 熊田 卓, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 金森 明, 多田 俊史, 北畠 秀介, 長谷川 綾平, 伊藤 隆徳, 安藤 祐資, 颯田 祐介, 田中 達也, 曽根 康博, 福里 利夫
肝臓 Vol. 54 ( 11 ) page： 755-764 2013.11
-
腹腔鏡下胆嚢摘出術後13年目に生じた金属クリップを核とした胆管結石の1例 Reviewed
山本 健太, 金森 明, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 多田 俊史, 安東 直人, 新家 卓郎, 坂井 圭介, 安田 諭, 安藤 祐資, 木村 純, 曽根 康博, 熊田 卓
日本消化器内視鏡学会雑誌 Vol. 55 ( 5 ) page： 1667-1672 2013.5
-
Oral supplementation with branched-chain amino acid granules prevents hepatocarcinogenesis in patients with hepatitis C-related cirrhosis: A propensity score analysis Reviewed
Toshifumi Tada Takashi Kumada Hidenori Toyoda Seiki Kiriyama Makoto Tanikawa Yasuhiro Hisanaga Akira Kanamori Shusuke Kitabatake Takuro Niinomi Takanori Ito Ryohei Hasegawa Yusuke Ando Kenta Yamamoto Tatsuya Tanaka
Hepatology research Vol. 44 ( 3 ) page： 288 - 295 2013.4
-
Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients Reviewed
Kumada T, Toyoda H, Tada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Niinomi T, Yasuda S, Andou Y, Yamamoto K, Tanaka J
Journal of Hepatology Vol. 58 ( 3 ) page： 427-33 2013
-
肝切除を基本とした肝細胞癌の治療戦略 Invited Reviewed
多田 俊史, 熊田 卓, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 金森 明, 新家 卓郎, 長谷川 綾平, 伊藤 隆徳, 安田 諭, 安藤 祐資, 山本 健太, 田中 達也
消化器内科 Vol. 55 ( 5 ) page： 612-616 2012.11
-
この画像から何が読めるか? 肝腫瘤(図説) Invited Reviewed
山本 健太, 熊田 卓, 豊田 秀徳, 多田 俊史
肝胆膵画像 Vol. 14 ( 6 ) page： 542-545 2012.9
-
B型肝炎に対する核酸アナログ投与例の長期予後 Invited Reviewed
多田 俊史, 熊田 卓, 桐山 勢生, 谷川 誠, 豊田 秀徳, 久永 康宏, 金森 明, 新家 卓郎, 安東 直人, 坂井 圭介, 安田 諭, 木村 純, 安藤 祐資, 山本 健太
消化器内科 Vol. 54 ( 5 ) page： 608-613 2012.5